Steven P Sedlis

Summary

Country: USA

Publications

  1. ncbi Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease
    Steven P Sedlis
    New York University School of Medicine, New York, NY, USA
    Am J Cardiol 104:1647-53. 2009
  2. ncbi Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)
    William E Boden
    VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, NY, USA
    Am J Cardiol 104:1-4. 2009
  3. ncbi Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry
    Steven P Sedlis
    Section of Cardiology, 12W, New York VA Medical Center, 423 East 23rd Street, New York, NY 10010, USA
    J Am Coll Cardiol 40:1555-66. 2002
  4. ncbi Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry
    Steven P Sedlis
    New York VA Medical Center and New York University School of Medicine, New York, New York 10010, USA
    Am J Cardiol 94:118-20. 2004
  5. ncbi Successful revascularization of a long chronic total occlusion with blunt microdissection complicated by coronary artery dissection
    Jeffrey D Lorin
    Division of Cardiology, Department of Veterans Affairs, New York Harbor Healthcare System, New York, NY, USA
    J Invasive Cardiol 16:673-6. 2004
  6. ncbi A dual wire approach to severe ostial bifurcating renal artery stenosis
    Jeffrey D Lorin
    Division of Cardiology, VA New York Harbor Health System Manhattan Campus and New York University School of Medicine, New York, New York 10010, USA
    Catheter Cardiovasc Interv 67:956-60. 2006
  7. ncbi Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine and Veterans Affairs New York Harbor Health Care System, New York, New York, USA
    Am J Cardiol 111:185-9. 2013
  8. ncbi Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization
    Louis H Miller
    VA New York Harbor Health Care System New York Campus, New York, NY 10010, USA
    J Invasive Cardiol 24:309-15. 2012
  9. ncbi Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
  10. ncbi Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease
    Alana Choy-Shan
    Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York University School of Medicine, New York, New York 10010, USA
    Coron Artery Dis 23:354-8. 2012

Collaborators

Detail Information

Publications14

  1. ncbi Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease
    Steven P Sedlis
    New York University School of Medicine, New York, NY, USA
    Am J Cardiol 104:1647-53. 2009
    ..Although PCI did not reduce the risk of death or myocardial infarction when added to OMT for patients with CKD, it also was not associated with worse outcomes in this high-risk group...
  2. ncbi Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)
    William E Boden
    VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, NY, USA
    Am J Cardiol 104:1-4. 2009
    ....
  3. ncbi Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry
    Steven P Sedlis
    Section of Cardiology, 12W, New York VA Medical Center, 423 East 23rd Street, New York, NY 10010, USA
    J Am Coll Cardiol 40:1555-66. 2002
    ....
  4. ncbi Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry
    Steven P Sedlis
    New York VA Medical Center and New York University School of Medicine, New York, New York 10010, USA
    Am J Cardiol 94:118-20. 2004
    ..This study reports the outcome of patients with LV ejection fraction <35% in the randomized clinical trial and the physician-directed and patient choice registries of the AWESOME study...
  5. ncbi Successful revascularization of a long chronic total occlusion with blunt microdissection complicated by coronary artery dissection
    Jeffrey D Lorin
    Division of Cardiology, Department of Veterans Affairs, New York Harbor Healthcare System, New York, NY, USA
    J Invasive Cardiol 16:673-6. 2004
    ..The case was complicated by a long coronary artery dissection, with inability to access the true lumen. With favorable healing at 7 weeks, the true lumen was accessible which led to procedural success...
  6. ncbi A dual wire approach to severe ostial bifurcating renal artery stenosis
    Jeffrey D Lorin
    Division of Cardiology, VA New York Harbor Health System Manhattan Campus and New York University School of Medicine, New York, New York 10010, USA
    Catheter Cardiovasc Interv 67:956-60. 2006
    ..Using a single 7F sheath in each case, both renal artery branches were wired, and each branch was predilated and stented in a sequential fashion. Excellent angiographic results were obtained in both cases...
  7. ncbi Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine and Veterans Affairs New York Harbor Health Care System, New York, New York, USA
    Am J Cardiol 111:185-9. 2013
    ..However, increased mortality was found when the MPV increased over time after PCI. Monitoring the MPV after coronary revascularization might play a role in risk stratification...
  8. ncbi Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization
    Louis H Miller
    VA New York Harbor Health Care System New York Campus, New York, NY 10010, USA
    J Invasive Cardiol 24:309-15. 2012
    ..Real-world, long-term outcomes using an FFR-based revascularization strategy are unknown...
  9. ncbi Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
    ..We examined whether colchicine use was associated with a reduced risk of myocardial infarction (MI) in patients with gout...
  10. ncbi Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease
    Alana Choy-Shan
    Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York University School of Medicine, New York, New York 10010, USA
    Coron Artery Dis 23:354-8. 2012
    ..The purpose of this study was to assess the impact of rosiglitazone on survival in patients with diabetes mellitus (DM) and coronary artery disease (CAD)...
  11. ncbi Relation of elevated periprocedural blood glucose to long-term survival after percutaneous coronary intervention
    Binita Shah
    Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York, USA
    Am J Cardiol 96:543-6. 2005
    ..This study reports the correlation of periprocedural blood glucose with long-term survival in 1,746 patients who underwent percutaneous coronary intervention from 1990 to 2003 in a Department of Veterans Affairs hospital...
  12. ncbi Metabolic syndrome does not impact survival in patients treated for coronary artery disease
    Binita Shah
    VA New York Harbor Health Care System, New York, NY 10010, USA
    Coron Artery Dis 19:71-7. 2008
    ..We evaluated the effect of metabolic syndrome (a risk factor for the development of coronary artery disease) on survival in patients with established coronary artery disease...
  13. ncbi The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease
    Magdi M El-Omar
    Department of Medicine-Cardiology, New York University Medical School, New York, NY, USA
    Thromb Res 116:199-206. 2005
    ..Increased generation of prothrombotic ADP in these patients implies a potential benefit from therapeutic intervention with soluble forms of CD39...
  14. ncbi Rapid thrombectomy for treatment of macroembolization during percutaneous coronary intervention in the setting of acute myocardial infarction
    Jeffrey D Lorin
    Division of Cardiology, Department of Veterans Affairs, New York Harbor Healthcare System, New York Campus, New York, New York 10010, USA
    Catheter Cardiovasc Interv 59:219-22. 2003
    ..We report the use of the Export catheter as an urgent modality to aspirate thrombus that embolized down the left anterior descending artery during acute myocardial infarction...